Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Agitation,Psychomotor: full-pipeline trial registry
3 of 6 indexed Agitation,Psychomotor trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Agitation,Psychomotor: 6 US clinical trials tracked, 3 recruiting.
Agitation,Psychomotor is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Brent Forester, running 1 of these trials.
Enrollment posture brief
Registry condition agitationpsychomotor
OPEN 3 | RECR 50% | LATE 2 | EARLY 2 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Agitation,Psychomotor lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Agitation,Psychomotor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Agitation,Psychomotor is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Agitation,Psychomotor research.
Brent Forester accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Agitation,Psychomotor enrolment sits around 380 participants.
Median target enrolment is 380 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Agitation,Psychomotor research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Clinical Trial on Agitation in Alzheimer's Dementia
IGC Pharma
NCT05543681
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
Brent Forester
NCT03926520
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
Mclean Hospital
NCT04075435
Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation
Hennepin Healthcare Research Institute
NCT03211897
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation
Axsome Therapeutics
NCT04947553
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
BioXcel Therapeutics
NCT04276883
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Agitation,Psychomotor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Agitation,Psychomotor trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Agitation,Psychomotor page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Agitation,Psychomotor trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Brent Forester sponsors the most Agitation,Psychomotor trials on record, review their full trial history before evaluating a specific study. See Brent Forester's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Agitation,Psychomotor condition card totals 6 registered trials; most-linked intervention AXS-05 (dextromethorphan-bupropion); top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.